(Q46702724)

English

SEEDbodies: fusion proteins based on strand-exchange engineered domain (SEED) CH3 heterodimers in an Fc analogue platform for asymmetric binders or immunofusions and bispecific antibodies

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20299542

SEEDbodies: fusion proteins based on strand-exchange engineered domain (SEED) CH3 heterodimers in an Fc analogue platform for asymmetric binders or immunofusions and bispecific antibodies (English)

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20299542

1 reference

based on heuristic

inferred from title

author name string

Jonathan H Davis

1

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20299542

Christel Aperlo

2

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20299542

Yue Li

3

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20299542

Emmi Kurosawa

4

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20299542

Yan Lan

5

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20299542

Kin-Ming Lo

6

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20299542

James S Huston

7

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20299542

publication date

4 February 2010

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20299542

Protein Engineering Design and Selection

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20299542

23

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20299542

4

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20299542

195-202

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20299542

Design and expression of a stable bispecific scFv dimer with affinity for both glycophorin and N9 neuraminidase.

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZP094

21 January 2018

Stable heterodimers from remodeling the domain interface of a homodimer using a phage display library

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZP094

21 January 2018

Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZP094

21 January 2018

Bispecific antibody conjugates in therapeutics

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZP094

21 January 2018

Design and production of novel tetravalent bispecific antibodies

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZP094

21 January 2018

Human domain antibodies against virulence traits of Candida albicans inhibit fungus adherence to vaginal epithelium and protect against experimental vaginal candidiasis

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZP094

21 January 2018

Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZP094

21 January 2018

T cells armed with anti-CD3 x anti-CD20 bispecific antibody enhance killing of CD20+ malignant B cells and bypass complement-mediated rituximab resistance in vitro

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZP094

21 January 2018

Antibody-targeted interleukin 2 stimulates T-cell killing of autologous tumor cells

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZP094

21 January 2018

Selective targeting and potent control of tumor growth using an EphA2/CD3-Bispecific single-chain antibody construct

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZP094

21 January 2018

Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZP094

21 January 2018

Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZP094

21 January 2018

Synergistic antitumor effect of bispecific CD19 x CD3 and CD19 x CD16 diabodies in a preclinical model of non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZP094

21 January 2018

A revival of bispecific antibodies

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZP094

21 January 2018

An efficient route to human bispecific IgG.

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZP094

21 January 2018

Structure-guided SCHEMA recombination of distantly related beta-lactamases

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZP094

21 January 2018

Physically realistic homology models built with ROSETTA can be more accurate than their templates

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZP094

21 January 2018

High-affinity antigen binding by chelating recombinant antibodies (CRAbs).

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZP094

21 January 2018

Targeting ErbB2 and ErbB3 with a bispecific single-chain Fv enhances targeting selectivity and induces a therapeutic effect in vitro

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZP094

21 January 2018

Single variable domain-IgG fusion. A novel recombinant approach to Fc domain-containing bispecific antibodies

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZP094

21 January 2018

A bispecific recombinant immunotoxin, DT2219, targeting human CD19 and CD22 receptors in a mouse xenograft model of B-cell leukemia/lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZP094

21 January 2018

Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin.

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZP094

21 January 2018

Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibody

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZP094

21 January 2018

Hybrid hybridomas and their use in immunohistochemistry

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZP094

21 January 2018

Identifiers

10.1093/PROTEIN/GZP094

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20299542

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20299542

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46702724&oldid=2127383505"